Clinical trial
Irinotecan Plus Radiation Therapy Followed By Chemotherapy in Treating Patients…
NCT00027612 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00027612 |
|---|---|
| Title | Irinotecan Plus Radiation Therapy Followed By Chemotherapy in Treating Patients With Glioblastoma Multiforme |
| Official title | Pilot And Phase II Trial Of Irinotecan And Radiation Followed By Irinotecan And BCNU In Glioblastoma Multiforme Patients |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors |
| Intervention type | Drug, Radiation |
| Interventions | carmustine, irinotecan hydrochloride, radiation therapy |
| Enrollment | 58 |
| Start date | Jul 1, 2002 |
| Primary completion | Oct 1, 2006 |
| Completion | Jul 1, 2009 |
| First posted | Jun 17, 2003 |
| Last update posted | Dec 7, 2016 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: